This article, featuring insights from James Blakemore and Leigh Shelford, explores how ESCMID 2025 marked a shift from technology-led innovation to outcome-led diagnostics. Covering key themes including AMR, syndromic testing, sequencing, and AI, it highlights why usability, integration, and real-world impact are now critical to platform success.
We've distilled the essence of successful diagnostic system development into this 10-minute guide - it's your compass in the intricate world of diagnostics, highlighting critical considerations essential for turning ambitious ideas into tangible solutions.
In a recent investigation on digital health innovation in the UK, we uncovered several hurdles that hinder progress. Here, we outline five and signpost resources to help innovators overcome them.
Bioprocessing technology is developing rapidly due to the automation of data collection and processing. But as Richard Owen (Head of Biology) and Arianna Rech (Bioprocessing Lead) explain, there is more that needs to be done to keep up with industry demand.
CDP and technology innovation catalyst CPI today launch A Strategic Technology Roadmap for the UK In Vitro Diagnostics Industry, a major new report for industry leaders, government, and the UK’s health tech companies.
Our Roadmap defines the key technologies and strategies that can place the UK at the forefront of the IVD industry.
Pregnancy screening, cancer treatment, organ transplant – digital PCR testing has the power to enhance clinical decision-making. What’s needed to take it mainstream?
Having developed a highly effective liquid biopsy system to isolate CTCs, Vortex Biosciences needed our technical expertise and manufacturing experience to improve the system’s disposable cartridge for reliable performance and high-volume production.
Senior Consultant Sergio Malorni shares seven principles we apply when conducting technology due diligence, whether for rights acquisition or investment in the company which owns the target technology.
In collaboration with deep tech innovation partner CPI and supported by Innovate UK, Cambridge Design Partnership is constructing a new actionable capability and technology roadmap for the in vitro diagnostics industry.
With urgent and important demand for LFTs, jeopardizing performance, ease-of-use, supply chain availability, and low cost isn’t an option – but sustainability strategies are evolving in response to consumer expectations.
Ice cream and blood are two things you probably don’t want to think about simultaneously, but how a substance flows is a vitally important consideration for many products.